Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2024
Archives
Exploring the global history and future of psychedelics
Psychedelics have long been a topic of fascination and controversy, their use wavering between medical marvel and social menace. To delve deeper into the global history of psychedelics, their impact on mental health treatment, and their future prospects, we spoke with Professor Erika Dyck from the University of Saskatchewan.
Who will staff the psychedelic resurgence?
Who will staff the psychedelic resurgence? Erika Dyck, Professor and Canada Research Chair in History of Health & Social Justice from the University of Saskatchewan, provides an intriguing answer to this question.
Will psychedelic research and the ‘psychedelic renaissance’ create another generational divide?
Erika Dyck, Canada Research Chair in History of Health & Social Justice at the University of Saskatchewan, discusses changing attitudes to psychedelics and the challenges in forming a strong evidence base from available psychedelic research.
The forgotten story of women within the history of psychedelics
Women are integral to the history of psychedelics; however, their contributions have often not figured as prominently in stories of daring experiments or discoveries made by charismatic mind explorers.
What is at stake in the psychedelic renaissance?
Professor Erika Dyck, Canada Research Chair in the History of Health & Social Justice, discusses the extensive history and growing medical application of psychedelics known as the psychedelic renaissance.
Dr. Erika Dyck – Researching psychedelics in Medicine
Historical insights and perspectives on the psychedelic renaissance and its potential to address increased mental health burdens/
What is the Psychedelic Renaissance and what can we learn from its history
Psychedelic therapies are breathing optimism back into modern psychiatry. Substances like psilocybin mushrooms, MDMA, and ketamine are showing clinical promise in a number of treatment-resistant categories of mental disorders, and we are beginning to see a psychedelic renaissance.
The history of psychedelics and why psychedelic stories matter
Erika Dyck delves into the history of psychedelics, exploring how these substances have piqued the interest and influenced the attitudes of individuals across academia, culture, and medicine.
Psychedelic therapies are returning to psychiatry
Professor Erika Dyck, Canada Research Chair in History of Health & Social Justice at the University of Saskatchewan, looks to psychedelic therapies outside the pharmaceutical industry to aid mental illness.
